Humanized skeletal muscle
Described herein is a method for producing a chimeric non-human animal expressing a human a MYF5, MYOD, MRF4 gene or a combination thereof gene comprising: a) generating an MYF5, MYOD, MRF4 or combination thereof null non-human animal cell, wherein both copies of the non-human MYF5, MYOD, MRF4 gene or combination thereof carry a mutation that prevents production of functional MYF5, MYOD, MRF4 protein or combination thereof in said non-human animal; b) creating a MYF5, MYOD, MRF4 or combination thereof null non-human blastocyst by somatic cell nuclear transfer comprising fusing a nucleus from said MYF5, MYOD, MRF4 or combination thereof null non-human animal cell of a) into an enucleated non-human oocyte and activating said oocyte to divide so as to form an MYF5, MYOD, MRF4 or combination thereof null non-human blastocyst; c) introducing human stem cells into the MYF5, MYOD, MRF4 or combination null non-human blastocyst of b); and d) implanting said blastocyst from c) into a pseudopregnant surrogate non-human animal to generate a chimeric non-human animal expressing human MYF5, MYOD, MRF4 or combination thereof.
1. A method for producing a chimeric pig embryo comprising:
a) generating a porcine cell with a homozygous disruption of MYF5, MYOD, and MYF6 genes in its genome, wherein the cell is not capable of expressing MYF5 gene, MYOD gene, and MYF6 gene;
b) introducing the cell of a) into an enucleated pig oocyte to produce a pig embryo;
c) culturing the pig embryo of b) to the morula or blastocyst stage; and
d) introducing human pluripotent stem cells into the inner mass cells of the morula or blastocyst of c),
wherein the human pluripotent stem cells comprise intact human MYF5 genes, MYOD genes, and MYF6 genes in its genome.
2. The method of claim 1 , wherein the pluripotent stem cell is an induced pluripotent stem cell.
3. The method of claim 2 , wherein the induced pluripotent cell is formed from a fibroblast cell.